Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Update to Johnson & Johnson PFA platform gains FDA approval
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.
FDA approves Bayer's finerenone to treat wide range of heart failure patients
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.
FDA details multiple Class I recalls for Edwards Lifesciences surgical devices
Edwards Lifesciences has recalled more than 61,000 medical devices due to the risk of a small piece of wire becoming exposed. No patient injuries have been reported at this time.
CMS proposes Medicare coverage for renal denervation
This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

The American Medical Association (AMA) has declared climate change as a major healthcare emergency. Sunrises and sunsets have become increasingly red in recent years with additional particulate matter in the atmosphere from larger, massive wild fires. Photo by Dave Fornell

Killer heat: How climate change could lead to more cardiovascular deaths

A new study to examine the relationship between extreme-heat events and cardiovascular mortality found that the hottest days can indeed be deadly.

The Boston Scientific Acurate neo2,. Abbott Portico and the new Edwards Sapien X4 TAVR valves were hot topics of discussion at TCT 2022. #TVT #TVT22 #TVT2022

VIDEO: TAVR's long-term impact on patient care

One thing was clear at TVT 2022 in Chicago: TAVR's popularity over surgery is changing the way physicians think about patient care.

FDA announces another recall for troubled heart device after a patient death

This latest recall involves the device's batteries, which are separating due to a "welding defect."

Links to all the late-breaking structural heart studies at TVT 2022

Here are links to more information for all the late-breaking presentations at the 2022 Transcatheter Valve Therapies (TVT) Structural Heart Summit.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

VIDEO: How to build a structural heart program

Charles Davidson, MD, clinical chief of cardiology and medical director of the Bluhm Cardiovascular Institute, Northwestern University, explains what hospitals need to consider when starting a new structural heart program.

Concerns about overuse of stress testing after PCI may be unwarranted

The majority of patients undergoing stress tests have symptoms consistent with obstructive coronary artery disease.

. Plaque erosion detection by the proposed AI algorithm in four cases, with each column showing one case. From top to bottom are the original images, ground truth, and predicted plaque erosion by our proposed method respectively.

New AI model detects plaque erosion in arteries

Detecting plaque erosion can offer an early warning sign of restricted blood flow to the heart, which can cause heart attacks.

How do Omicron and Delta compare on chest imaging?

Researchers found that 37% of patients with Omicron had CT scans that were considered normal compared to 15% with Delta.

Clinical

Update to Johnson & Johnson PFA platform gains FDA approval

FDA approves Bayer's finerenone to treat wide range of heart failure patients

FDA details multiple Class I recalls for Edwards Lifesciences surgical devices

CMS proposes Medicare coverage for renal denervation

ASE shares new recommendations for evaluating LV diastolic function, HFpEF